Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group (Q42686887)
scientific article published on September 1998
Language:
Current Data About Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group
(P31) (Q13442814)
(P248)
(P698) 9829441
(P813) Saturday, November 4, 2017

(P304) 885-900
(P248)
(P698) 9829441
(P813) Saturday, November 4, 2017

(P433) 5
(P248)
(P698) 9829441
(P813) Saturday, November 4, 2017

(P478) 20
(P248)
(P698) 9829441
(P813) Saturday, November 4, 2017

(P577) Tuesday, September 1, 1998
(P248)
(P698) 9829441
(P813) Saturday, November 4, 2017

(P921) (Q118551)
(P887)

(Q173022)
(P887)

(P1433) (Q15716601)
(P248)
(P698) 9829441
(P813) Saturday, November 4, 2017

(P1476) "Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group" (language: en)
(P248)
(P698) 9829441
(P813) Saturday, November 4, 2017

(P2093) Anzueto A
(P1545) 1
(P248)
(P698) 9829441
(P813) Saturday, November 4, 2017

Niederman MS
(P1545) 2
(P248)
(P698) 9829441
(P813) Saturday, November 4, 2017

Tillotson GS
(P1545) 3
(P248)
(P698) 9829441
(P813) Saturday, November 4, 2017

(P2860) (Q40696189)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980071-4
(P813) Thursday, January 7, 2021
(P887)

(Q40460295)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980071-4
(P813) Thursday, January 7, 2021
(P887)

(Q34737818)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980071-4
(P813) Thursday, January 7, 2021
(P887)

(Q40934462)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980071-4
(P813) Thursday, January 7, 2021
(P887)

(Q43573338)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980071-4
(P813) Thursday, January 7, 2021
(P887)

(Q73913243)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980071-4
(P813) Thursday, January 7, 2021
(P887)

(Q34180835)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980071-4
(P813) Thursday, January 7, 2021
(P887)

(Q43631132)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980071-4
(P813) Thursday, January 7, 2021
(P887)

(Q74666042)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980071-4
(P813) Thursday, January 7, 2021
(P887)

(Q39297796)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980071-4
(P813) Thursday, January 7, 2021
(P887)

(Q54147580)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980071-4
(P813) Thursday, January 7, 2021
(P887)

(Q34718973)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980071-4
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article published on September 1998

External Links
(P356) 10.1016/S0149-2918(98)80071-4
(P698) 9829441